Instytut Medycyny Wsi Im. Witolda Chodzki
- Address
- Ul. Dra Kazimierza Jaczewskiego 2, 20-090 Lublin, Poland
Instytut Medycyny Wsi Im. Witolda Chodzki - Diabetic Foot Infection Research
Instytut Medycyny Wsi Im. Witolda Chodzki (Witold Chodźko Institute of Rural Medicine) is a specialized research institution focused on investigating innovative therapeutic approaches for complex infectious diseases. The center has established expertise in conducting advanced clinical trials evaluating novel treatment modalities for diabetic complications, particularly those affecting rural and underserved populations.
- Bacteriophage therapy for antibiotic-resistant diabetic foot infections
- Novel antibiotic development and comparative efficacy studies for diabetic foot ulcers
- Wound healing assessment and infection classification in diabetic patients
The institute is actively engaged in cutting-edge research on diabetic foot infections, including Phase 2b and Phase 3 trials examining both innovative biological therapies and next-generation antibiotics. Their research portfolio includes evaluation of topical bacteriophage therapy targeting multi-drug resistant pathogens such as Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus, as well as comparative studies of advanced antimicrobial agents like contezolid versus standard treatments. This comprehensive approach positions the institute at the forefront of addressing the growing challenge of treatment-resistant infections in diabetic populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Micurx Pharmaceuticals Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Instytut Medycyny Wsi Im. Witolda Chodzki
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults with Moderate or Severe Diabetic Foot Infections | Micurx Pharmaceuticals Inc. | Phase III | Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aztreonam | 1 | Unknown | 2023-03-17 | 2023-03-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.